Vidalta® 10 mg & 15 mg prolonged-release tablets for cats
Vidalta is licensed for the treatment of hyperthyroidism, a common hormonal disease of middle aged to older cats. Vidalta only needs to be given once daily as the tablets are formulated to release the active, carbimazole, over twenty four hours.
Presentation
10 mg prolonged-release tablets
15 mg prolonged-release tablets
Active ingredients
Vidalta 10 mg tablets contain 10 mg carbimazole
Vidalta 15 mg tablets contain 15 mg carbimazole
Target species
Cats
Indications for use
Treatment of hyperthyroidism and hyperthyroidism-associated clinical signs in cats.
Packaging
30 or 100 Vidalta 10 mg or 15 mg tablets in a white high-density polyethylene tub.
Legal Category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: March 2023